S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
OTCMKTS:BAYRY

Bayer Aktiengesellschaft - BAYRY Price Target & Analyst Ratings

$15.93
+0.07 (+0.44%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$15.89
▼
$16.04
50-Day Range
$14.86
▼
$16.86
52-Week Range
$11.41
▼
$18.45
Volume
1.05 million shs
Average Volume
992,341 shs
Market Capitalization
N/A
P/E Ratio
13.73
Dividend Yield
2.20%
Price Target
$78.00

Bayer Aktiengesellschaft Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 9 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
3/31/22 to 3/31/23		1 Month Ago
3/1/22 to 3/1/23		3 Months Ago
12/31/21 to 12/31/22		1 Year Ago
3/31/21 to 3/31/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
9 Buy rating(s)
8 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Bayer Aktiengesellschaft Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BAYRY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Bayer Aktiengesellschaft Stock vs. The Competition

TypeBayer AktiengesellschaftMedical CompaniesS&P 500
Consensus Rating Score
2.56
2.64
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside2,001.71% Upside98.62% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/6/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Equal Weight
1/3/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Neutral
12/5/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral
11/14/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Sebastian Bray
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy€76.00 ➝ €70.00
11/9/2022Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetHold ➝ Hold€69.00 ➝ €54.00
8/30/2022Exane BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Outperform
8/16/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy€75.00 ➝ €79.00
5/19/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy€90.00 ➝ €96.00
5/11/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight€85.00 ➝ €90.00
3/14/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy
1/31/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Buy
11/15/2021AlphaValue
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeBuy
11/10/2021Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingNeutral
10/29/2021Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy
5/26/2021DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy
5/13/2021Bryan, Garnier & Co
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeSell ➝ Neutral
1/6/2021Nord/LB
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy
10/1/2020HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold
10/1/2020Commerzbank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold
9/9/2020BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform
(Data available from 3/31/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BAYRY Price Target - Frequently Asked Questions

What is Bayer Aktiengesellschaft's consensus rating?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Bayer Aktiengesellschaft stock is Moderate Buy based on the current 4 hold ratings and 5 buy ratings for BAYRYthe . Learn more on BAYRY's analyst rating history.

Do Wall Street analysts like Bayer Aktiengesellschaft more than its competitors?

Analysts like Bayer Aktiengesellschaft less than other Medical companies. The consensus rating for Bayer Aktiengesellschaft is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how BAYRY compares to other companies.

Is Bayer Aktiengesellschaft being downgraded by Wall Street analysts?

Over the previous 90 days, Bayer Aktiengesellschaft's stock had 2 downgrades by analysts.

What analysts cover Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft has been rated by JPMorgan Chase & Co., and Morgan Stanley in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (OTCMKTS:BAYRY) was last updated on 3/31/2023 by MarketBeat.com Staff